Peptidomimetic Drug Screening Service

Services

Online Inquiry

Peptidomimetic Drug Screening Service

As one of the world's leading biotechnology companies, CD BioSciences has state-of-the-art equipment and experienced staff. Our high-throughput peptidomimetic development platform can provide drug screening services for a variety of disease mechanisms according to customers' project needs, and meet the needs of global customers in drug discovery and other related fields.


Introduction to Drug Screening

  • Drug screening is a step in the modern drug development process to test and obtain specific physiologically active compounds. It refers to the process of selecting compounds with higher activity from a large number of compounds or new compounds through standardized experimental methods.
  • During the screening process of drug lead compounds, 40%-60% of the lead compounds are eliminated in the subsequent validation links (drug absorption, distribution, metabolism, secretion and toxicity testing). 72% of drug development costs are wasted on: increasing clinical costs, unpredictable regulatory environments in the body, and drug side effects. Therefore, the selection of high-quality lead compounds is a crucial process in drug screening.
  • CD BioSciences peptidomimetic drug screening adopts a cell-based phenotype screening method to evaluate the biological activity, pharmacological effect and medicinal value of peptidomimetic molecules that may be used as drugs.

Our Services

CD BioSciences provides peptidomimetic drug screening services by disease classification.

CancerCancer

Peptidomimetics are ideal components for cancer therapy because of their advantages in production, such as mimicking natural interactions between native proteins or molecules; targeting therapy or cancer diagnosis; and delivering drugs across biological barriers.

Neurological DiseaseNeurological Diseases

More than 600 neurological disorders have been identified worldwide, affecting hundreds of millions of people worldwide. Peptidomimetics can be used as potential nervous system therapeutic drugs due to their small side effects and good membrane penetration.

Metabolic DiseaseMetabolic Diseases

With the development of economy, a variety of metabolic diseases are rapidly rising worldwide and seriously affect people's lives. The shortcomings of the current series of peptide drugs limit the possibility of their further treatment and development, and the search for new peptidomimetic drugs will bring new opportunities.

Immunology and InflammationImmunology and Inflammation

Dysfunction of the immune system can lead to autoimmune diseases, inflammatory diseases and cancer. In the process of new drug discovery, peptidomimetic have attracted widespread attention because of their good targeting, low cytotoxicity, and high oral bioavailability as immunotherapy and related inflammatory drugs.

Our Service Processes

Our Service Processes

CD BioSciences is dedicated to providing a variety of services for peptidomimetic drug screening. The types of diseases we target are not limited to the above-mentioned ones, and we can provide customized services according to the client's project direction. As long as you are interested in any aspect of peptidomimetic drugs, please contact us for the best solution.

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.